TANDEM DIABETES CARE INC (TNDM) › Cash & EquivalentsTANDEM DIABETES CARE INC (TNDM) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2011: $8.66M2012: $17.16M2013: $124.39M2014: $31.18M2015: $43.09M2016: $44.68M2017: $13.70M2018: $41.83M2019: $51.17M2020: $94.61M2021: $71.18M2022: $172.52M2023: $58.87M2024: $69.23M2025: $90.63M$90.63M2011Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$90.63M+30.9%2024$69.23M+17.6%2023$58.87M-65.9%2022$172.52M+142.4%2021$71.18M-24.8%2020$94.61M+84.9%2019$51.17M+22.4%2018$41.83M+205.3%2017$13.70M-69.3%2016$44.68M+3.7%2015$43.09M+38.2%2014$31.18M-74.9%2013$124.39M+624.7%2012$17.16M+98.3%2011$8.66M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share